Search
for
Sort by
Research 181–210 of 926
- Oral isotretinoin combined with topical clobetasol 0.05% and tacrolimus 0.1% for the treatment of frontal fibrosing alopecia: a randomized controlled trial
- Update on the Treatment of Alopecia Areata
- Updates in the understanding and treatments of skin & hair disorders in women of color
- Current standards in the diagnostics and therapy of hair diseases - hair consultation
- Sublingual tofacitinib for alopecia areata: a roll‐over pilot clinical trial and analysis of pharmacokinetics
- Flexural Agminated Eruptive Nevi in Langerhans Cell Histiocytosis
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- Physiology and Medical Treatments for Alopecia
- Clinicopathological characteristics and treatment outcomes of fibrosing alopecia in a pattern distribution: A retrospective cohort study
- An overview of management of drug-induced hair and nail disorders
- Hair loss and its management in children
- Real-World Evidence for Baricitinib in the Treatment of Atopic Dermatitis and Alopecia Areata: Systematic Literature Review 2020–2023
- An update on diagnosis and treatment of female pattern hair loss
- Impact of Previous Alopecia Areata Treatment on Efficacy Responses up to Week 48 Following Ritlecitinib Treatment: A Post Hoc Analysis
- Korean Consensus Criteria for the Severity Classification of Alopecia Areata
- Dermatologic Adverse Events from Cancer Treatments
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- Atlas of Geriatric Dermatology
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Janus Kinase inhibitors in dermatology: a review
- British Hair and Nail Society
- Trichodystrophies: A hair-raising differential diagnosis
- Chemotherapy and Cutaneous Drug Reactions
- Compounding as a Current Therapeutic Option in Dermatology
- Diagnostic challenges in determining alopecia areata
- Reassessing frontal fibrosing alopecia
- Topical latanoprost acid for female androgenetic alopecia: a pilot proof-of-concept trial with mechanistic evidence of prostaglandin F2α receptor activation
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based Approach
- Corrective and Restorative Dermatology in Cancer Survivors: An Urgent Unmet Need!